that sensitivity analysis spells it out, but my thinking revolves around 0 performance fees and it still is a reasonable investment (assuming clients are sticky)
the swings will be exacerbated however because if performance remains poor then clients will eventually leave, in the same way that if performance is at 15%pa then clients will flock. So it’s a highly leveraged play in that regard.
- Forums
- ASX - By Stock
- MAM
- Ann: Appendix 4D and HY19 Financial Report
Ann: Appendix 4D and HY19 Financial Report, page-8
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAM (ASX) to my watchlist
(20min delay)
|
|||||
Last
51.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.00M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 995 | 51.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2030 | 0.510 |
1 | 2000 | 0.500 |
3 | 9577 | 0.495 |
1 | 4000 | 0.490 |
1 | 3876 | 0.485 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 19477 | 1 |
0.535 | 9000 | 1 |
0.550 | 23828 | 1 |
0.560 | 8953 | 1 |
0.565 | 15002 | 1 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
MAM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online